![Daniel Ritz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Daniel Ritz is currently Chief Scientific Officer at BioVersys AG since 2025.
Dr. Ritz was Head-Biology Technologies & Discovery at Idorsia Pharmaceuticals Ltd.
Daniel Ritz active positions
| Companies | Position | Start |
|---|---|---|
| BIOVERSYS AG | Chief Tech/Sci/R&D Officer | 03/11/2025 |
Former positions of Daniel Ritz
| Companies | Position | End |
|---|---|---|
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Corporate Officer/Principal | 01/01/2025 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Daniel Ritz
